Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients
Kenji Yoshimura, Ryoji Maekura, Toru Hiraga, Seigo Kitada, Keisuke Miki, Mari Miki, Yoshitaka TateishiDepartment of Respiratory Medicine, Toneyama National Hospital, Osaka, JapanBackground: Tiotropium partially relieves exertional dyspnea and reduces the risk of congestive heart failure in chronic o...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-05-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/effects-of-tiotropium-on-sympathetic-activation-during-exercise-in-sta-a9801 |
| _version_ | 1818549704736112640 |
|---|---|
| author | Kitada S Hiraga T Maekura R Yoshimura K Tateishi Y Miki M Miki K |
| author_facet | Kitada S Hiraga T Maekura R Yoshimura K Tateishi Y Miki M Miki K |
| author_sort | Kitada S |
| collection | DOAJ |
| description | Kenji Yoshimura, Ryoji Maekura, Toru Hiraga, Seigo Kitada, Keisuke Miki, Mari Miki, Yoshitaka TateishiDepartment of Respiratory Medicine, Toneyama National Hospital, Osaka, JapanBackground: Tiotropium partially relieves exertional dyspnea and reduces the risk of congestive heart failure in chronic obstructive pulmonary disease (COPD) patients. However, its effect on the sympathetic activation response to exercise is unknown.Aims: This study aimed to determine whether tiotropium use results in a sustained reduction in sympathetic activation during exercise.Methods: We conducted a 12-week, open-label (treatments: tiotropium 18 µg or oxitropium 0.2 mg × 3 mg), crossover study in 17 COPD patients. Treatment order was randomized across subjects. The subjects underwent a pulmonary function test and two modes of cardiopulmonary exercise (constant work rate and incremental exercise) testing using a cycle ergometer, with measurement of arterial catecholamines after each treatment period.Results: Forced expiratory volume in 1 second and forced vital capacity were significantly larger in the tiotropium treatment group. In constant exercise testing, exercise endurance time was longer, with improvement in dyspnea during exercise and reduction in dynamic hyperinflation in the tiotropium treatment group. Similarly, in incremental exercise testing, exercise time, carbon dioxide production, and minute ventilation at peak exercise were significantly higher in the tiotropium treatment group. Plasma norepinephrine concentrations and dyspnea intensity were also lower during submaximal isotime exercise and throughout the incremental workload exercise in the tiotropium treatment group.Conclusion: Tiotropium suppressed the increase of sympathetic activation during exercise at the end of the 6-week treatment, as compared with the effect of oxipropium. This effect might be attributed to improvement in lung function and exercise capacity and reduction in exertional dyspnea, which were associated with decreases in respiratory frequency and heart rate and reduced progression of arterial acidosis.Keywords: chronic obstructive pulmonary disease (COPD), anticholinergics, exercise testing, sympathetic activation  |
| first_indexed | 2024-12-12T08:36:49Z |
| format | Article |
| id | doaj.art-471f3af707334314a11e93985801bb64 |
| institution | Directory Open Access Journal |
| issn | 1176-9106 1178-2005 |
| language | English |
| last_indexed | 2024-12-12T08:36:49Z |
| publishDate | 2012-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of COPD |
| spelling | doaj.art-471f3af707334314a11e93985801bb642022-12-22T00:30:54ZengDove Medical PressInternational Journal of COPD1176-91061178-20052012-05-012012default109118Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patientsKitada SHiraga TMaekura RYoshimura KTateishi YMiki MMiki KKenji Yoshimura, Ryoji Maekura, Toru Hiraga, Seigo Kitada, Keisuke Miki, Mari Miki, Yoshitaka TateishiDepartment of Respiratory Medicine, Toneyama National Hospital, Osaka, JapanBackground: Tiotropium partially relieves exertional dyspnea and reduces the risk of congestive heart failure in chronic obstructive pulmonary disease (COPD) patients. However, its effect on the sympathetic activation response to exercise is unknown.Aims: This study aimed to determine whether tiotropium use results in a sustained reduction in sympathetic activation during exercise.Methods: We conducted a 12-week, open-label (treatments: tiotropium 18 µg or oxitropium 0.2 mg × 3 mg), crossover study in 17 COPD patients. Treatment order was randomized across subjects. The subjects underwent a pulmonary function test and two modes of cardiopulmonary exercise (constant work rate and incremental exercise) testing using a cycle ergometer, with measurement of arterial catecholamines after each treatment period.Results: Forced expiratory volume in 1 second and forced vital capacity were significantly larger in the tiotropium treatment group. In constant exercise testing, exercise endurance time was longer, with improvement in dyspnea during exercise and reduction in dynamic hyperinflation in the tiotropium treatment group. Similarly, in incremental exercise testing, exercise time, carbon dioxide production, and minute ventilation at peak exercise were significantly higher in the tiotropium treatment group. Plasma norepinephrine concentrations and dyspnea intensity were also lower during submaximal isotime exercise and throughout the incremental workload exercise in the tiotropium treatment group.Conclusion: Tiotropium suppressed the increase of sympathetic activation during exercise at the end of the 6-week treatment, as compared with the effect of oxipropium. This effect might be attributed to improvement in lung function and exercise capacity and reduction in exertional dyspnea, which were associated with decreases in respiratory frequency and heart rate and reduced progression of arterial acidosis.Keywords: chronic obstructive pulmonary disease (COPD), anticholinergics, exercise testing, sympathetic activation http://www.dovepress.com/effects-of-tiotropium-on-sympathetic-activation-during-exercise-in-sta-a9801 |
| spellingShingle | Kitada S Hiraga T Maekura R Yoshimura K Tateishi Y Miki M Miki K Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients International Journal of COPD |
| title | Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients |
| title_full | Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients |
| title_fullStr | Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients |
| title_full_unstemmed | Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients |
| title_short | Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients |
| title_sort | effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients |
| url | http://www.dovepress.com/effects-of-tiotropium-on-sympathetic-activation-during-exercise-in-sta-a9801 |
| work_keys_str_mv | AT kitadas effectsoftiotropiumonsympatheticactivationduringexerciseinstablechronicobstructivepulmonarydiseasepatients AT hiragat effectsoftiotropiumonsympatheticactivationduringexerciseinstablechronicobstructivepulmonarydiseasepatients AT maekurar effectsoftiotropiumonsympatheticactivationduringexerciseinstablechronicobstructivepulmonarydiseasepatients AT yoshimurak effectsoftiotropiumonsympatheticactivationduringexerciseinstablechronicobstructivepulmonarydiseasepatients AT tateishiy effectsoftiotropiumonsympatheticactivationduringexerciseinstablechronicobstructivepulmonarydiseasepatients AT mikim effectsoftiotropiumonsympatheticactivationduringexerciseinstablechronicobstructivepulmonarydiseasepatients AT mikik effectsoftiotropiumonsympatheticactivationduringexerciseinstablechronicobstructivepulmonarydiseasepatients |